You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,580,306


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,580,306
Title:Particles for use in a pharmaceutical composition
Abstract: The invention provides a method of making a composition for inhalation which includes the step of mixing particles of additive material having a diameter of not more than 2 .mu.m with active particles, wherein the additive material is suitable for promoting the dispersal of active particles upon aerolization of a dry, powder in a dry powder inhaler.
Inventor(s): Staniforth; John Nicholas (Bath, GB), Morton; David Alexander Vodden (Bath, GB)
Assignee: Vectura Limited (Chippenham, GB)
Application Number:10/433,135
Patent Claim Types:
see list of patent claims
Use; Composition; Process; Formulation; Delivery;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,580,306: A Comprehensive Guide

Introduction

When analyzing a patent, understanding its scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will delve into the details of United States Patent 8,580,306, providing a thorough analysis of its scope, claims, and the broader patent landscape.

Understanding Patent Scope

Patent scope is a critical aspect of patent quality and is often measured using metrics such as independent claim length and independent claim count. These metrics help in assessing the breadth and clarity of the patent claims[3].

Patent Claims: An Overview

Patent claims define the boundaries of what is protected by the patent. They are the legal definitions of the invention and are crucial for determining infringement. Here are some key points to consider:

Independent Claims

Independent claims stand alone and do not rely on other claims. They are typically broader and more comprehensive than dependent claims. The length and count of independent claims can indicate the scope of the patent[3].

Dependent Claims

Dependent claims build upon independent claims and are narrower in scope. They often provide additional details or specific embodiments of the invention.

Analyzing the Claims of US Patent 8,580,306

To analyze the claims of US Patent 8,580,306, one would need to review the patent document itself. Here are some steps to follow:

Identify Independent and Dependent Claims

  • Determine the number and length of independent claims.
  • Analyze how dependent claims expand on the independent claims.

Claim Language and Scope

  • Evaluate the clarity and specificity of the claim language.
  • Assess whether the claims are overly broad or narrowly defined.

Claim Construction

  • Understand how the claims are constructed to define the invention.
  • Identify any ambiguities or potential issues with claim construction.

Patent Examination Process

The examination process can significantly impact the final scope of the patent claims. Here’s how it works:

Initial Examination

  • The patent office reviews the application to determine if the invention is novel, non-obvious, and useful[4].

Office Actions and Responses

  • The examiner may issue office actions, which the applicant must respond to by amending the claims or arguing against the examiner's findings.
  • This process can narrow the scope of the claims over time[3].

Continuation Procedures

  • Applicants can file continuation applications to pursue additional claims or to address issues raised during the initial examination[4].

The Broader Patent Landscape

Understanding the broader patent landscape is essential for contextualizing the significance and potential impact of US Patent 8,580,306.

Global Dossier and International Patent Offices

  • The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP offices[1].
  • Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), can help identify similar patents globally[1].

Prior Art and Citation Data

  • The Common Citation Document (CCD) consolidates prior art cited by multiple offices, providing a comprehensive view of the prior art landscape[1].

Tools and Resources for Patent Search

Several tools and resources are available to help in the analysis and search of patents:

Patent Public Search

  • This tool provides enhanced access to prior art and is a powerful resource for searching patents[1].

Patent and Trademark Resource Centers (PTRCs)

  • These centers offer local search resources and training in patent search techniques[1].

Public Search Facility

  • The USPTO Public Search Facility in Alexandria, VA, provides access to patent and trademark information in various formats[1].

Legal and Policy Considerations

The legal and policy environment surrounding patents can influence the scope and claims of a patent.

Small Claims Patent Court

  • There have been discussions and studies on the feasibility of a small claims patent court to address issues related to patent litigation costs and complexity[2].

Patent Quality and Scope

  • Debates over patent quality often focus on the breadth and clarity of patent claims. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Case Study: US Patent 8,580,306

While specific details of US Patent 8,580,306 are not provided here, the following steps would be taken in a real analysis:

Review the Patent Document

  • Obtain the patent document and review the claims, description, and drawings.

Analyze Claim Language

  • Evaluate the clarity, specificity, and breadth of the claims.

Examine the Examination History

  • Review the office actions and responses to understand how the claims were narrowed or broadened during the examination process.

Compare with Prior Art

  • Use tools like the CCD and Global Dossier to identify prior art and understand how the patent fits into the broader patent landscape.

Key Takeaways

  • Patent Scope: Understanding the scope of a patent is crucial and can be measured using metrics like independent claim length and count.
  • Claim Analysis: Analyzing the claims involves identifying independent and dependent claims, evaluating claim language, and understanding claim construction.
  • Examination Process: The patent examination process can significantly impact the final scope of the patent claims.
  • Global Landscape: Considering the global patent landscape through tools like Global Dossier and international patent databases is essential.
  • Legal and Policy: The legal and policy environment, including discussions on small claims patent courts, can influence patent scope and claims.

FAQs

What is the importance of independent claims in a patent?

Independent claims are crucial as they define the broadest scope of the invention and stand alone without relying on other claims.

How does the patent examination process affect the scope of patent claims?

The examination process can narrow the scope of patent claims through office actions and responses, leading to more specific and clear claims.

What is the Global Dossier service, and how does it help in patent searching?

The Global Dossier service provides access to the file histories of related applications from participating IP offices, allowing users to see the patent family and related data for a specific application.

Why is prior art important in patent analysis?

Prior art helps in understanding the novelty and non-obviousness of the invention, and tools like the CCD consolidate prior art cited by multiple offices.

What are the implications of a small claims patent court on patent litigation?

A small claims patent court could potentially reduce litigation costs and complexity, making it easier for smaller entities to enforce their patent rights.

Sources

  1. USPTO: Search for patents - USPTO
  2. ACUS: U.S. Patent Small Claims Court
  3. SSRN: Patent Claims and Patent Scope
  4. YJOLT: What Is the Probability of Receiving a US Patent?

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,580,306

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,580,306

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0029261.5Nov 30, 2000
United Kingdom0030946.8Dec 19, 2000
United Kingdom0124009.2Oct 5, 2001
PCT Information
PCT FiledNovember 30, 2001PCT Application Number:PCT/GB01/05305
PCT Publication Date:June 06, 2002PCT Publication Number: WO02/43700

International Family Members for US Patent 8,580,306

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1267866 ⤷  Subscribe C300583 Netherlands ⤷  Subscribe
European Patent Office 1267866 ⤷  Subscribe CA 2013 00015 Denmark ⤷  Subscribe
European Patent Office 1267866 ⤷  Subscribe 92166 Luxembourg ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.